Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.2
-184.97%
40%
—
423.25%
80%
—
5 Years
Score4.2
Net Growth-184.97%
Net Trend40%
Net Income Consistency—
Rev Growth423.25%
Rev Trend80%
Revenue Consistency—
Bicycle Therapeutics Ltd fundamental performance
Between 2020 and 2025, revenue grew from $ 10M to $ 72M and net income went from -$ 51M to -$ 218M. Revenue increased in 4 of those 5 years; net income in 2.
Bicycle Therapeutics Ltd currently holds a 5-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.06 | — |
1 Year2025-08-12 | $ 7.22 | -43.77% |
5 Years2021-08-12 | $ 28.93 | -85.97% |
All Time2019-05-23 | $ 12.00 | -66.17% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-05-23 |
|---|---|---|---|---|
| Price | $ 4.06 | $ 7.22 | $ 28.93 | $ 12.00 |
| Return | — | -43.77% | -85.97% | -66.17% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 61M | -$ 190M | $ 510M |
| 2025 | $ 72M | -$ 218M | $ 628M |
| 2024 | $ 35M | -$ 169M | $ 879M |
| 2023 | $ 26M | -$ 180M | $ 526M |
| 2022 | $ 14M | -$ 112M | $ 339M |
| 2021 | $ 11M | -$ 66M | $ 438M |
| 2020 | $ 10M | -$ 51M | $ 135M |
| IPO2019 | $ 13M | -$ 30M | $ 92M |
Explore beyond BCYC
You're looking at Bicycle Therapeutics Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
